Search

Author/Creator Grous, John

1. A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study). (6th November 2014)

Authors:
Wang-Gillam, Andrea; Picozzi, Vincent; Crocenzi, Todd; Morse, Michael; Zeh, Herbert; Fine, Robert; Murphy, Aimee; Skoble, Justin; Lemmens, Edward; Ferber, Sandy; Rosen, Allan; Grous, John; Dubensky, Thomas W; Brockstedt, Dirk; Jaffee, Elizabeth; Le, Dung
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM). Issue 2 (December 2015)

Authors:
Hassan, Raffit; Alley, Evan; Kindler, Hedy; Antonia, Scott; Jahan, Thierry; Thomas, Anish; Honarmand, Somayeh; Murphy, Aimee; Grous, John; Brockstedt, Dirk
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗